Cargando…
Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456293/ https://www.ncbi.nlm.nih.gov/pubmed/37623909 http://dx.doi.org/10.3390/metabo13080933 |
| _version_ | 1785096662013706240 |
|---|---|
| author | Chaby, Lauren E. Lasseter, Heather C. Contrepois, Kévin Salek, Reza M. Turck, Christoph W. Thompson, Andrew Vaughan, Timothy Haas, Magali Jeromin, Andreas |
| author_facet | Chaby, Lauren E. Lasseter, Heather C. Contrepois, Kévin Salek, Reza M. Turck, Christoph W. Thompson, Andrew Vaughan, Timothy Haas, Magali Jeromin, Andreas |
| author_sort | Chaby, Lauren E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10456293 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104562932023-08-26 Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 Chaby, Lauren E. Lasseter, Heather C. Contrepois, Kévin Salek, Reza M. Turck, Christoph W. Thompson, Andrew Vaughan, Timothy Haas, Magali Jeromin, Andreas Metabolites Correction MDPI 2023-08-09 /pmc/articles/PMC10456293/ /pubmed/37623909 http://dx.doi.org/10.3390/metabo13080933 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Chaby, Lauren E. Lasseter, Heather C. Contrepois, Kévin Salek, Reza M. Turck, Christoph W. Thompson, Andrew Vaughan, Timothy Haas, Magali Jeromin, Andreas Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 |
| title | Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 |
| title_full | Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 |
| title_fullStr | Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 |
| title_full_unstemmed | Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 |
| title_short | Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609 |
| title_sort | correction: chaby et al. cross-platform evaluation of commercially targeted and untargeted metabolomics approaches to optimize the investigation of psychiatric disease. metabolites 2021, 11, 609 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456293/ https://www.ncbi.nlm.nih.gov/pubmed/37623909 http://dx.doi.org/10.3390/metabo13080933 |
| work_keys_str_mv | AT chabylaurene correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT lasseterheatherc correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT contrepoiskevin correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT salekrezam correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT turckchristophw correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT thompsonandrew correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT vaughantimothy correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT haasmagali correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 AT jerominandreas correctionchabyetalcrossplatformevaluationofcommerciallytargetedanduntargetedmetabolomicsapproachestooptimizetheinvestigationofpsychiatricdiseasemetabolites202111609 |